Seranova

New Haven, United States Founded: 2020 • Age: 6 yrs
CRO offering chemical proteomics services for preclinical development of drug
Annual revenue - Latest available
Total funding $10.0M 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 9 Brand Intelligence

About Seranova

Seranova is a company based in New Haven (United States) founded in 2020. Seranova has raised $10 million across 1 funding round. Seranova offers products and services including REAP Technology. Seranova operates in a competitive market with competitors including Liberation Labs, NJ Bio, Shantani Proteome Analytics, Kinaxo Biotechnologies and Scala Biodesign, among others.

  • Headquarter New Haven, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $10 M (USD)

    in 1 rounds

  • Latest Funding Round
    $10 M (USD), Series A

    Feb 01, 2024

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Seranova

Seranova offers a comprehensive portfolio of products and services, including REAP Technology.

Product name locked
Category locked
Primary

Analyzes autoantibodies in blood to discover new disease therapeutics.

People of Seranova

Headcount 1-10
Employee Profiles 6
Employee Profiles
People
Brent McKenzie
Chief Scientific Officer
People
Joe Derla
Associate Scientist
People
Aaron Ring
Founder
People
Emi Lutz
Scientist II

Unlock access to complete

Funding Insights of Seranova

Seranova has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Seranova

Investments
Premium access

Investment portfolio details for Seranova

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Seranova

Premium access

Detailed financials for Seranova

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Seranova Comparisons

Seranova Primary company
Description
CRO offering chemical proteomics services for preclinical de...
Location
New Haven, United States
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Seranova

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Seranova

Seranova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Liberation Labs, NJ Bio, Shantani Proteome Analytics, Kinaxo Biotechnologies and Scala Biodesign, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Fermentation products are manufactured and commercialized via CRO services.
Locked Locked Locked
Clinical development services are provided for biotechnology applications.
Locked Locked Locked
Drug discovery services are delivered via chemical-proteomics technologies.
Locked Locked Locked
Chemical proteomics for cellular target profiling and drug discovery services
Locked Locked Locked
Computational protein design solutions are delivered at scale.
Locked Locked Locked
Provider of peptide drug discovery and development services for global pharmaceutical industries
Premium access

Detailed competitors of Seranova

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Seranova

Premium access

Complete news archive for Seranova

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seranova

Seranova was founded in 2020 and raised its 1st funding round 4 years after it was founded.

Seranova is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.

Seranova is a funded company, having raised a total of $10M across 1 funding round to date.

Seranova was founded in 2020 and is based in New Haven, United States. As a contract research organization in the biotechnology sector, chemical proteomics services are provided by the company to support preclinical drug development. Operations focus on analytical techniques that enable target identification and validation in early-stage pharmaceutical research, serving clients in the life sciences industry.

Seranova's top competitors include Liberation Labs, NJ Bio and Shantani Proteome Analytics.

Seranova offers REAP Technology.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available